UK Court Clarifies Obviousness Rule In Levaquin Suit
A U.K. appeals court has upheld a determination of validity for Daiichi Pharmaceutical Co.'s patent for the active ingredient in the antibiotic Levaquin, ruling that an invention is not obvious if...To view the full article, register now.
Already a subscriber? Click here to view full article